diabetes

Sanofi plans sales layoffs—again—in primary care, diabetes
Fierce Pharma
Thu, 04/4/19 - 12:16 pm
Sanofi
layoffs
primary care
diabetes
drug reps
Cigna’s Express Scripts PBM To Cap Insulin Costs Amid Drug Price Scrutiny
Forbes
Wed, 04/3/19 - 10:06 am
Express Scripts
PBMs
insulin
diabetes
drug pricing
Better Diabetes Care: Healthcare Startups Say They’ll Get Paid When Patients Get Better
Forbes
Mon, 04/1/19 - 11:00 pm
diabetes
value-based care
patients
startups
Lawmakers seek to make new interchangeable insulin policy permanent
BioCentury
Mon, 04/1/19 - 10:56 pm
insulin
diabetes
legislation
Diabetes group nods to Vascepa, sending Amarin stock higher
Biopharma Dive
Thu, 03/28/19 - 07:59 pm
ADA
Vascepa
Amarin
diabetes
What's Next for Lexicon Pharmaceuticals?
Motley Fool
Mon, 03/25/19 - 10:21 pm
Lexicon Pharmaceuticals
sotagliflozin
Zynquista
Sanofi
diabetes
Lilly reveals Humalog pricing details amid larger scrutiny over insulin costs
Biopharma Dive
Mon, 03/25/19 - 10:15 pm
Eli Lilly
drug pricing
Humalog
insulin
diabetes
Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure
Forbes
Fri, 03/22/19 - 10:12 pm
diabetes
PBMs
insurers
insulin
drug pricing
Roche Seeks Millions in Diabetes Test Strip Lawsuit
BioSpace
Thu, 03/21/19 - 06:46 pm
Roche
diabetes
Alliance Medical Products
Novo Nordisk seeks FDA nod for oral diabetes pill
Drug Delivery Business News
Thu, 03/21/19 - 09:49 am
Novo Nordisk
FDA
semaglutide
diabetes
Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva
Pharmaceutical Business Review
Wed, 03/20/19 - 12:16 pm
Novo Nordisk
Teva Pharmaceutical
patents
Victoza
diabetes
Mylan and Hospira both recall injected drugs after particulate discovered in vials
Fierce Pharma
Wed, 03/20/19 - 09:58 am
Mylan
Hospira
recalls
diabetes
chemotherapy
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Fierce Pharma
Mon, 03/18/19 - 05:05 pm
Novo Nordisk
diabetes
Teva Pharmaceutical
Victoza
semaglutide
3 Top Diabetes Stocks to Watch in March
Yahoo/Motley Fool
Sun, 03/17/19 - 08:04 pm
diabetes
AstraZeneca
DexCom
Medtronic
devices
How Much Difference Will Eli Lilly's Half-Price Insulin Make?
NPR
Sun, 03/10/19 - 12:04 pm
Eli Lilly
insulin
diabetes
drug pricing
Humalog
Livongo preps for $1B IPO
Drug Delivery Business News
Fri, 03/8/19 - 10:53 pm
Livongo
IPOs
digital health
diabetes
Abbott Labs
Senators seek changes to FDA guidance to speed entry of insulin biosimilars
Endpoints
Mon, 03/4/19 - 07:36 pm
diabetes
insulin
biosimilars
FDA
Senate
In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data
Endpoints
Mon, 03/4/19 - 10:20 am
Novo Nordisk
Trulicity
Ozempic
Eli Lilly
diabetes
AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study
Endpoints
Mon, 02/25/19 - 09:50 am
AstraZeneca
Brilinta
diabetes
blood thinner
clinical trials
U.S. Senators launch bipartisan probe into rising insulin prices
Yahoo/Reuters
Sat, 02/23/19 - 04:30 pm
insulin
drug pricing
diabetes
Senate

Pages